CoChat

The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance

Open access

The DOI matches its Crossref record; 79 of the 83 references it cites were found in a registry or an index; 1 of the 13 sources its claims cite were checked for support.

Abstract

Pituitary dysfunction is a recognised, but potentially underdiagnosed complication of traumatic brain injury (TBI). Post-traumatic hypopituitarism (PTHP) can have major consequences for patients physically, psychologically, emotionally and socially, leading to reduced quality of life, depression and poor rehabilitation outcome. However, studies on the incidence of PTHP have yielded highly variable findings. The risk factors and pathophysiology of this condition are also not yet fully understood. There is currently no national consensus for the screening and detection of PTHP in patients with TBI, with practice likely varying significantly between centres. In view of this, a guidance development group consisting of expert clinicians involved in the care of patients with TBI, including neurosurgeons, neurologists, neurointensivists and endocrinologists, was convened to formulate national guidance with the aim of facilitating consistency and uniformity in the care of patients with TBI, and ensuring timely detection or exclusion of PTHP where appropriate. This article summarises the current literature on PTHP, and sets out guidance for the screening and management of pituitary dysfunction in adult patients with TBI. It is hoped that future research will lead to more definitive recommendations in the form of guidelines.

Overview

CoChat Summary

TL;DR

This British Neurotrauma Group guidance summarizes the literature and provides consensus recommendations for screening and managing pituitary dysfunction after traumatic brain injury (TBI) in adults. It advises against routine acute-phase pituitary testing, recommends targeted cortisol testing only when insufficiency is clinically suspected, and recommends screening at 3–6 months for patients admitted for >48 hours.

Key findings

  • A meta-analysis of 14 studies reported pooled post-traumatic hypopituitarism prevalence of 27.5%; by TBI severity, pituitary dysfunction was detected in 16.8% with mild TBI (GCS 13–15), 10.9% with moderate TBI (GCS 9–12), and 35.5% with severe TBI (GCS 3–8).
  • Acute anterior hypopituitarism prevalence was reported as 53%–78%, while chronic rates varied from 5.4% to 76.4% at >12 months; GH and gonadotrophin deficiencies were the most commonly identified deficits.
  • The guidance recommends no routine acute-phase pituitary function testing or plasma/serum cortisol measurement; if cortisol insufficiency is suspected, give empirical hydrocortisone 50 mg 6–8 hourly intravenously/intramuscularly, or 50–100 mg as an initial intravenous bolus followed by 4–8 mg/hour, after taking a random cortisol sample, and discuss with endocrinology.
  • Patients admitted for >48 hours after TBI should be screened at 3–6 months; advised 09:00 cortisol action limits are <100 nmol/L (start oral hydrocortisone 10 mg on waking, 5 mg at noon, 5 mg at 17:00 and refer urgently), 100–400 nmol/L (refer and advise steroid sick day rules), and >400 nmol/L (no routine endocrinology referral).

Methods

  • A guidance development group of expert clinicians involved in TBI care—including neurosurgeons, neurologists, neurointensivists, and endocrinologists—was convened; an initial meeting was held in October 2014 at Robinson College, Cambridge, UK, with drafts revised by email to consensus and final approval by all members.
  • Evidence types and recommendation grades followed the Agency for Healthcare Policy and Research framework; the document summarizes current literature on post-traumatic hypopituitarism and sets out consensus recommendations, mostly graded IV,C or III,B.
  • No formal systematic review, search strategy, or primary data collection is described; this is a consensus guidance document rather than an original study.

Limitations

  • The paper states that there is currently no national consensus for screening, incidence studies have highly variable findings, risk factors and pathophysiology are not fully understood, and no definitive recommendations can yet be made; it calls for a multicentre study powered to determine true incidence, predictors, and optimal methods/timing of endocrine investigation.
  • The paper states that symptoms overlap considerably between TBI itself and pituitary dysfunction and have poor specificity, and that static blood tests have recognized limitations, with definitive investigation frequently requiring dynamic hormone testing interpreted by an experienced endocrinologist.
  • Evident from the text: most recommendations rely on expert opinion/level IV evidence and are graded C, with few higher-grade recommendations, and the guidance does not describe a formal systematic literature search or meta-analytic method.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/jnnp-2016-315500

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Recommendations for screening for pituitary dysfunction in the acute phase of TBI. SIADH, syndrome of inappropriate antidiuretic hormone; TBI, traumatic brain injury.
Figure 1 Recommendations for screening for pituitary dysfunction in the acute phase of TBI. SIADH, syndrome of inappropriate antidiuretic hormone; TBI, traumatic brain injury.CC BY · PubMed Central
Figure 2 Symptoms suggestive of pituitary dysfunction.
Figure 2 Symptoms suggestive of pituitary dysfunction.CC BY · PubMed Central
Figure 3 Recommendations for screening for pituitary dysfunction in patients with traumatic brain injury (TBI) following discharge.
Figure 3 Recommendations for screening for pituitary dysfunction in patients with traumatic brain injury (TBI) following discharge.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 1 Not valid · 8 Not checked · 6 Own results and interpretations

5 more claims

Create a free account to see all 16 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 6
  • Probably not a substantial claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 79 references

Research works printed but not linked: 4

  1. US Department of Health and Human Services; Public Health Service; Agency for Health Care and Policy Research, 1994, Acute lower back problems in adults. Clinical Practice Guideline 14
  2. NICE, Head injury: assessment and early management [CG176], NICE
  3. Ghigo, 2005, Consensus guidelines on screening for hypopituitarism following traumatic brain injury, Brain Inj, 19, 711, 10.1080/02699050400025315 · DOI · Paper page
  4. Sesmilo, 2007, Endocrine evaluation of patients after brain injury: what else is needed to define specific clinical recommendations?, Hormones, 6, 132, 10.14310/horm.2002.1111013 · DOI · Paper page

Cited by

See all 111

Metadata

Authors
Tan, C. L., Alavi, S. A., Baldeweg, S. E., Belli, A., Carson, A., Feeney, C., Goldstone, A. P., Greenwood, R., Menon, D. K., Simpson, H. L., Toogood, A. A., Gurnell, M., & Hutchinson, P. J.
Affiliations
  • University of Cambridge (GB)
  • Queen's Medical Centre (GB)
  • University College Hospital (GB)
  • Queen Elizabeth Hospital Birmingham (GB)
  • University of Edinburgh (GB)
  • Imperial College Healthcare NHS Trust (GB)
  • UCL Queen Square Institute of Neurology (GB)
Corresponding author
Gurnell, Mark
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2017-08-31
Volume
88
Issue
11
Pages
971-981
ISSN
  • 0022-3050 (ISSN-L)
  • 1468-330X
OpenAlex
W2752710898
Cited by
111
References
83
Citations by year
2026: 11 · 2025: 16 · 2024: 17 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 14 · 2019: 16 · 2018: 7
FWCI
1.48
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • National Institute for Health and Care Research (NIHR-RP-R3-12-013)
  • Surgical Reconstruction and Microbiology Research Centre
  • Medical Research Council
  • NIHR Cambridge Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords
post-traumatic hypopituitarism, pituitary dysfunction, traumatic brain injury, adult patients, quality of life, depression, rehabilitation outcomes, risk factors, pathophysiology
MeSH terms
Brain Injuries, Traumatic, Adrenal Insufficiency, Adult, Female, Follow-Up Studies, United Kingdom, Humans, Hypopituitarism, Inappropriate ADH Syndrome, Male, Mass Screening, Patient Admission, Pituitary Function Tests, Pituitary Gland, Anterior, Early Diagnosis, Early Medical Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance. https://app.cochat.ai/papers/10.1136/jnnp-2016-315500
The paper
Tan, C. L., Alavi, S. A., Baldeweg, S. E., Belli, A., Carson, A., Feeney, C., Goldstone, A. P., Greenwood, R., Menon, D. K., Simpson, H. L., Toogood, A. A., Gurnell, M., & Hutchinson, P. J. (2017). The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2016-315500

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.